Opening https://www.businesswire.com/news/home/20230326005073/en/Incyte-Announces-Japanese-Approval-of-Pemazyre%C2%AE-pemigatinib-for-the-Treatment-of-Patients-with-MyeloidLymphoid-Neoplasms-MLNs